D-1518-2019 Class III Terminated

Recalled by Lupin Pharmaceuticals Inc. — Baltimore, MD

FDA drug recall D-1518-2019 was initiated by Lupin Pharmaceuticals Inc. on Jul 17, 2019 and is designated Class III. Reason for recall: Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation. The recall status is terminated (terminated Sep 14, 2020). Affected quantity: 33,939 tubes.

Recall details

Product Type
Drugs
Report Date
Jul 31, 2019
Initiation Date
Jul 17, 2019
Termination Date
Sep 14, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
33,939 tubes

Product description

Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-545-01

Reason for recall

Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.

Distribution pattern

Nationwide within the United States

Code information

Lot #: K800245, Exp. Dec 2019; K900036 Exp. Sep 20; K900153, Exp. 09/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1518-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1518-2019. Report a data issue: hello@regdatalab.com.